HCID 178513455, compound → HCID 178513454, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([C:9](=[O:50])[C:10](=[C:41]2[NH:45][C:44]3[CH:46]=[CH:47][CH:48]=[CH:49][C:43]=3[NH:42]2)[C:11]([C:13]2[CH:14]=[C:15]([S:19]([NH:22][C:23](=[NH:40])[N:24]3[CH2:29][CH2:28][N:27](C(OCC4C=CC=CC=4)=O)[CH2:26][CH2:25]3)(=[O:21])=[O:20])[CH:16]=[CH:17][CH:18]=2)=[O:12])[CH:5]=[C:6]([F:8])[CH:7]=1>[Pd].C(O)C>[F:1][C:2]1[CH:3]=[C:4]([C:9](=[O:50])[C:10](=[C:41]2[NH:42][C:43]3[CH:49]=[CH:48][CH:47]=[CH:46][C:44]=3[NH:45]2)[C:11]([C:13]2[CH:14]=[C:15]([S:19]([NH:22][C:23]([N:24]3[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]3)=[NH:40])(=[O:20])=[O:21])[CH:16]=[CH:17][CH:18]=2)=[O:12])[CH:5]=[C:6]([F:8])[CH:7]=1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
10% Pd—C (210 mg) was added to an ethanol (20 mL) solution of the compound (205 mg) obtained in Example 10, followed by stirring at room temperature for 19 hours under hydrogen atmosphere (1 atom). The insoluble matter was separated by filtration, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform/methanol=50/1), and recrystallized from ethyl acetate/n-hexane to obtain N-({3-[3-(3,5-difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl]phenyl}sulfonyl)piperazine-1-carboximidamide (46 mg).
Workup
- customThe insoluble matter was separated by filtration
- concentrationthe filtrate was concentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (chloroform/methanol=50/1)
- customrecrystallized from ethyl acetate/n-hexane
Sources & evidence
- ORD record
- ord-e58bfe62e7274f44aebf40affb56f14b
- Source dataset
- uspto-grants-2011_06
- Patent number
- US07960562B2
Reaction notes
Loading…